Feeds
Dermatologists will soon get some high-tech help deciding which suspicious-looking moles should be removed and checked for melanoma, the deadliest form of skin cancer.
Medtronic Inc. paid its former Chief Executive William Hawkins just under $9 million in total compensation during his last full year leading the company, which has since hired a General Electric executive to try and revive its lackluster business.
Help is on the way to consumers confused by the jumble of sun protection numbers, symbols and other claims on sunscreens. Starting next summer, consumers can start looking for SPF 15 bottles with the label "broad spectrum" and feel confident they're being protected from an increased risk of cancer.
For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney stones and pancreatic damage.
Federal health regulators said Wednesday they have approved a new drug from AstraZeneca to treat a rare form of thyroid cancer that can be fatal when it spreads to other parts of the body.
The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug shown to prolong the lives of patients with advanced skin cancer.
Everyday across the U.S., tens of thousands of patients in the Veterans Administration health system start their day by answering questions about how they feel.
The Food and Drug Administration is approving medical devices too slowly. Or too quickly — depending on whom you ask.
The government on Tuesday unexpectedly rejected what appeared to be the most promising candidate among a class of new diet drugs, wiping out hopes for a new medication to fight obesity anytime soon.
A Democratic Congressman is pressing federal regulators to complete their long-delayed safety review of an antibacterial chemical found in thousands of hand sanitizers, soaps and other products.
The maker of the painkiller Darvon is pulling the drug off the market at the request of public health officials who say the more than 50-year-old pill causes potentially deadly heart rhythms.
Federal health officials are calling on manufacturers of heart-zapping defibrillators to fix long-standing problems with the emergency devices that have triggered dozens of recalls and occasionally have led to injuries and death.
Shares of biotech drugmaker Dendreon jumped Thursday after Medicare officials issued a mostly positive assessment of the company's prostate cancer therapy, setting the stage for the government to pay for thousands of patients to receive the drug.
For the second time this year, federal inspectors have dismissed allegations by Food and Drug Administration scientists who say they were pressured and harassed by their managers into approving medical devices against their judgment.
In the 1990s, the pharmaceutical industry repeatedly was named the most profitable industry in the world. More than a decade later, the industry tops a more dubious list: the No. 1 source of fraud-related settlements with the Department of Justice, an advocacy group says.
Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches on Friday, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of the condition.
Pfizer's purchase of King Pharmaceuticals announced Tuesday represents a $3.6 billion investment in an emerging class of painkillers that are designed to be less addictive than older pills such as OxyContin. The new products have been touted by federal health officials as an important way to curb prescription drug abuse, but they are relatively untested in the marketplace.
Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients with a history of heart disease.
The Food and Drug Administration must update its scientific tools for reviewing prescription drugs, medical devices and tracking food safety, according to a research plan laid out Wednesday by agency leadership.
Federal health regulators are warning biotech drug maker Gilead Sciences Inc. about quality control violations at a California factory.
Johnson & Johnson executives and the Food and Drug Administration both shouldered the blame Thursday for a secret recall in which hired contractors quietly bought up defective painkillers to clear them from store shelves.
In spring 2009, a group of contract workers, going mostly to gas station convenience stores, bought up thousands of bottles of Motrin that had been determined to be defective but not dangerous. The workers had been hired for Johnson and Johnson, which wanted to remove the pills from the market without issuing a public recall.
Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.
Federal health regulators have issued warnings to the makers of Canada Dry ginger ale and Lipton tea for making unsubstantiated nutritional claims about their green tea-flavored beverages.
Andrew White returned from a nine-month tour in Iraq beset with signs of post-traumatic stress disorder: insomnia, nightmares, constant restlessness. Doctors tried to ease his symptoms using three psychiatric drugs, including a potent anti-psychotic called Seroquel.
Log In | Register
